Accompanied a study order, see H5223
Email me when H 1080 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 1080. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill adds a new section to state law that bars health plans, contracts, or insurance certificates from ending or reducing coverage of a brand‑name drug just because a generic version has been approved by the FDA. Coverage can only be changed after the generic has been available in the Commonwealth for at least three calendar months, as verified by the Department of Public Health. This aims to give patients time to transition to lower‑cost alternatives without losing access.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 1080
3 free questions a day, no accountHearings
- Health Insurance Matters - Pharmacy, Contracting, ReformJoint Committee on Financial Services · Oct 1, 2025
History
- Accompanied a study order, see H5223
- Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-1
- Hearing rescheduled to 10/01/2025 from 10:30 AM-11:20 PM in B-1 and Virtual Hearing updated to New End Time
- Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in B-1 and Virtual Hearing location changed
- Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in A-1 and Virtual Hearing location changed
- Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-2
- Senate concurred
- Referred to the committee on Financial Services
Sponsors
- Brian M. Ashe · sponsor
- Angelo J. Puppolo, Jr.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 1080 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 1080 freeOr ask your AI assistant about H 1080 directly:
Add to Claude, ChatGPT or Cursor